Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Endocrinology

Background:

• Vitamin D deficiency is prevalent in chronic kidney disease (CKD) patients.
• This deficiency is linked to endothelial dysfunction and increased cardiovascular disease risk.
• Flow-mediated vasodilation (FMD) is a key indicator of endothelial function.

Purpose of the Study:

• To conduct a meta-analysis assessing the impact of vitamin D treatment on FMD in CKD patients.
• To evaluate the efficacy of vitamin D supplementation in improving vascular function.

Main Methods:

• Systematic search of PubMed/Medline, Web of Science, Embase, and Cochrane for relevant randomized controlled trials (RCTs).
• Inclusion of RCTs using any vitamin D compound in CKD patients with FMD as the outcome.
• Application of fixed and random effects models to calculate standardized mean difference (SMD) and assess heterogeneity (I² statistics).

Main Results:

• Four RCTs involving 305 CKD patients (stages 3-4) were included.
• Vitamin D intervention demonstrated a significant amelioration of FMD (SMD 0.78, 95% CI 0.55-1.01) in a fixed-effects model.
• Substantial heterogeneity was observed (I² = 84%), with secondary random-model analysis also yielding significant results.

Conclusions:

• Short-term vitamin D intervention is associated with improved endothelial function (FMD) in CKD patients.
• These findings suggest potential benefits of vitamin D for vascular disease in CKD.
• Limitations include a small number of studies and short intervention durations.